MGR
★    

India,
2007-01-03 06:39
(6483 d 13:59 ago)

Posting: # 429
Views: 7,997
 

 Statistical analysis of a steady state study [PK / PD]

Hi to all,

As we are dealing with a steady state study, can any one guide me how to perform the statistical analysis, the parameters calculated (AUC0-tau, %PTF)or are there any other parameters to be calculated for steady state study. If there are any sites or information regarding steady state statistical analysis. Kindly let me know.

And also please tell me the which procedure (ANOVA- Linear Model) and tests to be used for statistical analysis using SAS software.

Thanks and regards,
MGR

Regards,
MGR
H_Rotter
★    

Germany,
2007-01-04 17:05
(6482 d 03:32 ago)

@ MGR
Posting: # 433
Views: 6,452
 

 Statistical analysis of a steady state study

Hi MGR!

Have a look at Helmut's post.

Especially for drugs with low accumulation, BE for Cmin may be very difficult to demonstrate; if ever possible (safety/efficacy) you may try to apply a wider acceptance range for this parameter (but keep an eye on recent developments, which may prevent this...).

❝ And also please tell me the which procedure(ANOVA- Linear Model) and tests to be used for statistical analysis using SAS software.


I think we had this already.

Regards,
Hermann
Imran
☆    

Mumbai,
2007-01-10 10:52
(6476 d 09:46 ago)

@ MGR
Posting: # 449
Views: 6,712
 

 Steady state

Dear MGR

For SS study u need to estimate Cmin, Cmax, AUC0-tau, PTF.

These parameters can be calulated by any PK software such as WinNonlin or SAS. SS achived can be proved statistically by regression analysis. For more information u can refer USFDA guidance or CPMP guidlines for Extended release product.

I hope ur querry is answere to some extent

regards

Dr.Imran Khan

Dr.Imran Khan
UA Flag
Activity
 Admin contact
23,240 posts in 4,884 threads, 1,655 registered users;
66 visitors (0 registered, 66 guests [including 12 identified bots]).
Forum time: 21:38 CEST (Europe/Vienna)

The epistemological value of probability theory is based on the fact
that chance phenomena, considered collectively and on a grand scale,
create non-random regularity.    Andrey Kolmogorov

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5